Related Experiment Video
Updated: Apr 24, 2026
Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats
Published on: March 11, 2016
Biomarkers in cardiorenal syndrome
Lui G Forni1, Lakhmir S Chawla
1Department of Critical Care, Western Sussex Hospitals Foundation Trust, Worthing, UK.
Insights
Biomarkers for acute kidney injury can aid in diagnosing cardiorenal syndrome. Using a panel of these biomarkers may soon guide effective clinical therapies for coexisting cardiac and kidney diseases.
Area of Science:
- Biomarkers
- Cardiorenal Syndrome
- Organ Cross-talk
Background:
- Cardiac and renal diseases frequently occur together.
- Diagnosis and treatment are challenging due to a lack of disease activity markers.
- Understanding organ cross-talk is crucial for effective therapies.
Purpose of the Study:
- To review current data on acute kidney injury biomarkers.
- To discuss their relevance in cardiorenal syndrome.
- To propose the use of biomarker panels for guiding therapy.
Main Methods:
- Literature review of commonly studied acute kidney injury biomarkers.
- Analysis of biomarker data in the context of cardiorenal syndrome.
- Discussion of potential therapeutic applications of biomarker panels.
Main Results:
- Several candidate molecules show promise for elucidating organ cross-talk.
- Biomarkers are essential for understanding the cardiorenal syndrome.
- Biomarker panels may offer valuable diagnostic and therapeutic information.
Conclusions:
- Biomarker panels hold potential for guiding therapy in cardiorenal syndrome.
- Advances in this field are rapid, with clinical applications expected soon.
- Improved diagnostics through biomarkers can enhance treatment strategies.
Abstract:
Cardiac and renal diseases often coexist. Treatment may prove difficult as early diagnosis and effective therapy may be hindered by a lack of robust markers of disease activity. However, several candidate molecules are now available which may help elucidate the complexities of organ cross-talk, enabling effective therapies. We discuss the available data on the commonly studied biomarkers of acute kidney injury with reference to the cardiorenal syndrome. Furthermore, we propose how the use of biomarkers as a panel may provide information which can guide therapy. Although this is a relatively new field, advances are rapid, and such options may well be available to the clinician soon.
Related Concept Videos
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:24Serum Studies: Renal Function Tests
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
01:25Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate